Press release
Neuroblastoma Industry 2019 Key Market Influencer as AG, LUMITOS AG, NANTGE Healthcare, Pfizer, GL Pharm Tech Corporation, Aetna, RxStrategies, etc
Market Research Future
Neuroblastoma Market - Highlights
Global Neuroblastoma market is anticipated to hold a market value of 2.60 billion in 2017 and is expected to grow at a CAGR of 3.7% during the forecast period. Neuroblastoma is a childhood cancer most commonly occurs in children below the age of 5 years. The neuroblast may cause due to the immature cell growth or mutation in the gene responsible for controlling cell proliferation. The increasing cases of childhood cancer, rising research on neuroblastoma treatment and increasing spending on cancer treatment is expected to drive market growth over the forecast period.
According to the American Society of Clinical Oncology (ASCO) April 2018 publication, every year, more than 700 children get diagnosed with neuroblastoma in the US and it is also indicated that neuroblastoma is the most common cancer in children younger than 1 year. It is more commonly found in boys compare to girls. The increasing cases of childhood cancer boost market growth during the forecast period.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6555
Despite the drivers, shortage of trained healthcare specialists and the high cost of this therapy can restrain the market growth over the assessment period.
Top Players:
Some of the prominent players in the global neuroblastoma market are United Therapeutics Corp., APEIRON Biologics AG, LUMITOS AG, NANTGE Healthcare, Pfizer Inc., GL Pharm Tech Corporation, Aetna Inc, RxStrategies, Inc., and others.
Segmentation:
Global Neuroblastoma Market has been segmented into diagnostics, treatment, and end user.
The market, on the basis of diagnostics, has been segmented into various tests, MIBG scan, imaging, and biopsy. The tests are further sub-segmented into bone marrow, tissue, urine, and blood.
The market, by treatment, has been segmented into surgery, chemotherapy, radiation therapy, stem cell transplant, immunotherapy, and monoclonal antibody treatment.
On the basis of end user, the global neuroblastoma market has been segmented into hospitals ambulatory surgical centers, diagnostic centers, research centers, and others.
Regional Analysis:
Geographically, the Americas is expected to dominate the global neuroblastoma market owing to the presence of well-developed healthcare sector, rising prevalence of infant cancer cases, and growing expenditure for the healthcare sector. Europe is expected to hold the second largest position in the global neuroblastoma market owing to the growing number of child healthcare centers for cancer treatment and raising awareness about the treatment for neuroblastoma. According to the Cancer Research UK May 2018 publication, around 100 infants are detected with neuroblastoma every year in the UK. This provides favorable backgrounds for the neuroblastoma market to grow.
Asia-Pacific is expected to be the fastest growing market owing to the increasing children cancer base and increasing developments in the healthcare segment.
According to the Neuroblastoma Australia organization October 2018 article, every year approximately 40 cases of neuroblastoma are indicated in Australia due to some unknown genetic problems which will support the market growth.
Furthermore, the Middle Eastern and African region is expected to account for the least market share in the global market.
Browse Complete 90 Pages Premium Research Report Enabled with 75 Respective Tables and Figures at https://www.marketresearchfuture.com/reports/neuroblastoma-market-6555
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroblastoma Industry 2019 Key Market Influencer as AG, LUMITOS AG, NANTGE Healthcare, Pfizer, GL Pharm Tech Corporation, Aetna, RxStrategies, etc here
News-ID: 1565479 • Views: …
More Releases from Market Research Future
Gigabit Internet Market 2024-2032: Comprehensive Growth Analysis, USD 57.8 Billi …
✿➤ Market Overview
The Gigabit Internet Market Industry is expected to grow from USD 15.63 Billion in 2024 to USD 57.8 Billion by 2032. The Gigabit Internet Market CAGR growth rate is expected to be around 17.76% during the forecast period 2024 - 2032.
Gigabit Internet refers to broadband internet service that provides speeds of 1 gigabit per second (Gbps) or higher, enabling faster downloads, uploads, and smoother streaming experiences. It supports…
Pigment Black Market to Witness Robust Expansion by 2032
The pigment black market encompasses a range of black pigments used across various industries, including automotive, construction, plastics, and coatings. These pigments are essential for providing deep black coloration and enhancing the visual appeal and performance of products. The market is characterized by a variety of black pigments, including carbon black, iron oxide black, and others, each with distinct properties and applications.
Overview of Pigment Black Market
Pigment Black Market Size was…
Vegetable Fatty Acids Market Global Industry Report, 2032
The vegetable fatty acids market has been experiencing notable growth, driven by increasing consumer demand for natural and sustainable products. These fatty acids, derived from various vegetable sources such as palm oil, soybean oil, coconut oil, and sunflower oil, are essential ingredients in numerous industrial applications. Their versatility and biodegradability make them attractive alternatives to synthetic chemicals, aligning with the global trend towards sustainability and environmentally friendly products.
Vegetable Fatty Acids…
Pigment Red 166 Market to Reach $2.5 Billion, Globally, by 2032
The global market for Pigment Red 166 (PR 166), a high-performance pigment known for its excellent lightfastness, heat resistance, and color strength, is experiencing robust growth. PR 166 is widely used in various applications, including plastics, coatings, inks, and textiles, due to its vibrant red hue and superior properties. This pigment is part of the azo pigment group and is valued for its stability and versatility, making it a preferred…
More Releases for Neuroblastoma
Neuroblastoma Drugs Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Neuroblastoma Drugs market.
Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under…
Neuroblastoma - Pipeline Insight and Review, H1 2018
Market Research HUB has added a new report titled "Neuroblastoma - Pipeline Review, H1 2018, which provides an overview of the Neuroblastoma (Oncology) pipeline landscape. Neuroblastoma is the cancer of the nerve tissues and neural crest cells of adrenal glands, neck, chest or spinal cord, occurring predominantly in children. It usually begins in the adrenal glands further spreading to other parts of the body. The predisposing factors involved in neuroblastoma include…
Neuroblastoma Treatment Pipeline Review H2 2017
Pune, India, 27th November 2017: WiseGuyReports announced addition of new report, titled “Neuroblastoma - Pipeline Review, H2 2017”.
Summary
Neuroblastoma is the cancer of the nerve tissues and neural crest cells of adrenal glands, neck, chest or spinal cord, occurring predominantly in children. It usually begins in the adrenal glands further spreading to other parts of the body. The predisposing factors involved in neuroblastoma include genetic conditions. Symptoms include lump in abdomen…
Neuroblastoma - Pipeline Insight and Therapeutic Assessment Reviewed in 2017
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Neuroblastoma - Pipeline Review, H2 2017”which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for pharmaceutical industry would rise at a positive CAGR during the period 2017-2022.
Click here for Free…
Neuroblastoma Treatment Market to Register Substantial Expansion by 2023
Neuroblastoma is the most common type of cancer in infants. The cancer is caused as a result of embryonal malignancy of sympathetic nervous system which arises from the neuroblasts. The cancer develops in the nerve tissues of adrenal, chest or spinal cord. Neuroblastoma is listed as a “rare disease” in the U.S. by the National Institute of Health (NIH), and Orphanet in Europe. The cancer is most prevalent in infants…
Global Neuroblastoma Treatment Market: Latest Trends and Insights 2023
Neuroblastoma is the most common type of cancer in infants. The cancer is caused as a result of embryonal malignancy of sympathetic nervous system which arises from the neuroblasts. The cancer develops in the nerve tissues of adrenal, chest or spinal cord. Neuroblastoma is listed as a “rare disease” in the U.S. by the National Institute of Health (NIH), and Orphanet in Europe. The cancer is most prevalent in infants…
